Fried Robert N has filed 6 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 503937 shares of Niagen Bioscience, Inc. ($NAGE) on February 19, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Niagen Bioscience, Inc. | $NAGE | Fried Robert N | Chief Executive Officer | A | Employee Stock Options (right to buy) | 503937 | $0.00 | 503,937.0000 | 86,619,000 | 9999.99% | 0.58% |
| April 9, 2025 | Niagen Bioscience, Inc. | $NAGE | Fried Robert N | Chief Executive Officer | M | Common Stock | 66667 | $3.30 | 1,646,728.0000 | 78,125,000 | 4.22% | 0.09% |
| April 9, 2025 | Niagen Bioscience, Inc. | $NAGE | Fried Robert N | Chief Executive Officer | M | Stock Options (right to buy) | 66667 | $0.00 | 0.0000 | 78,125,000 | 100.00% | 0.09% |
| Feb. 25, 2025 | Niagen Bioscience, Inc. | $NAGE | Fried Robert N | Chief Executive Officer | A | Performance Stock Unit | 1518600 | $0.00 | 1,518,600.0000 | 78,125,000 | 9999.99% | 1.94% |
| Feb. 12, 2025 | Niagen Bioscience, Inc. | $NAGE | Fried Robert N | Chief Executive Officer | A | Employee Stock Options (right to buy) | 492278 | $0.00 | 492,278.0000 | 78,125,000 | 9999.99% | 0.63% |
| Feb. 22, 2024 | Niagen Bioscience, Inc. | $NAGE | Fried Robert N | Chief Executive Officer | A | Employee Stock Options (right to buy) | 399568 | $0.00 | 399,568.0000 | 74,985,000 | 9999.99% | 0.53% |